Marché mondial des dispositifs de fermeture vasculaire à approximateurs actifs (VCD) – Tendances et prévisions de l’industrie jusqu’en 2029

Analyse du marché et de la taille des dispositifs de fermeture vasculaire à approximateurs actifs (VCD)

Selon les données de l’OMS, les accidents vasculaires cérébraux et les crises cardiaques sont responsables de plus de quatre décès sur cinq causés par des troubles cardiovasculaires, et un tiers de ces décès surviendrait avant l’âge de 70 ans. La Société européenne de cardiologie (ESC) (2021) rapporte que les maladies cardiovasculaires (MCV) tuent 3,9 millions de personnes chaque année en Europe et plus de 1,8 million de personnes dans l’Union européenne. Elles représentent environ 45 % de tous les décès en Europe et 37 % des décès au sein de l’Union européenne.

Français Data Bridge Market Research analyse que le marché des dispositifs de fermeture vasculaire à approximateurs actifs (VCD), qui était de 807,7 millions USD en 2021, devrait atteindre 1 451,27 millions USD d’ici 2029 et devrait connaître un TCAC de 7,60 % au cours de la période de prévision 2022 à 2029. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario de marché, le rapport de marché organisé par l’équipe de recherche sur le marché Data Bridge comprend également une analyse approfondie des experts, une épidémiologie des patients, une analyse du pipeline, une analyse des prix et un cadre réglementaire.

Portée et segmentation du marché des dispositifs de fermeture vasculaire à approximateurs actifs (VCD)     

Market Definition

After an angiography, a collagen or suture piece is utilised as a vascular closure device. Vascular closure devices are useful in angiogram leaves an artery puncture. The punctured arteries are sealed using vascular closure devices. The patients' bodies are not negatively affected by the vascular closure devices.

Active Approximators Vascular Closure Device (VCDs) Market Dynamics

Drivers

• High prevalence of cardiovascular diseases

In the entire world, cardiovascular diseases (CVDs) rank among the main causes of death. The American Heart Association (AHA) estimates that 18.6 million people died in 2019 as a result of CVDs, with the majority of these deaths occurring in Eastern Europe and Central Asia. According to the AHA's projections, 40.5 percent of the US population will have a CVD by 2030. Thus, the demand for catheterization and interventional treatments for diagnosing and treating CVDs is projected to rise as CVD prevalence rises. In the upcoming years, the market for active approximators vascular closure devices is projected to grow significantly due to the rising popularity of these treatments.

• Growing vascular closure device approvals as well as consumer inclination

The main factors fuelling the growth of the active approximators vascular closure devices market is the rising prevalence of cardiovascular illnesses in the population. Other indirect factors influencing the growth of the market include increasing consumer disposable income and increasing players' focus on large-bore vascular closure devices. Growing vascular closure device approvals as well as consumer inclination for minimally invasive procedures will create more fruitful chances for market expansion. Increased obesity rates will also pave the ground for market expansion.

Opportunities

• Growth in the number of hospitals and surgical centers

The growing patient population is a considerable need for surgical supplies (including medical equipment like vascular closure devices) at these recently opened surgical centres and hospitals. As the primary end users of vascular closure devices, the significant increase in hospitals and surgical facilities is anticipated to drive the growth of the active approximators vascular closure devices market.

Restraints/Challenges

• High cost of vascular closure devices

When compared to manual compression devices, vascular closure devices are more expensive. Vascular closure devices typically cost between $150 and $250, whereas manual compression devices cost between $15 and $25. VCD expenses essentially add to the patient's hospital bill, raise hospitals' per-patient expenses, and at the same time lower their earnings. On the other hand, manual compression devices have very cheap prices when compared to vascular closure devices. As a result, one of the main factors restricting the market's growth is the high price of vascular closure devices. Another significant barrier limiting the market for these devices is the fact that hospitals are not compensated for vascular closure devices.

This active approximators vascular closure device (VCDs) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the active approximators vascular closure device (VCDs) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Active Approximators Vascular Closure Device (VCDs) Market

The COVID-19 outbreak's statewide lockdowns, refusal of wound care services, and cancellation or postponement of elective procedures, the market for active approximators vascular closure devices suffered in 2020. In order to reserve or reallocate the limited capacities and resources (such hospital beds and patient care specialists) toward COVID-19 patient care, elective procedures were being refused (cancelled/postponed). Additionally, many nations had implemented curfews and lockdowns to reduce the rising number of COVID-19 instances. Patients were unable to visit clinics, hospitals, or OPDs as a result of these lockdowns. The expansion of the market for active approximators vascular closure devices is anticipated to be constrained by this temporary denial of non-emergent healthcare services. However, it is anticipated that demand for active approximator vascular closure devices would increase in the upcoming years.

Recent Development

• In July 2021, the new investigational product that is currently being developed, PerQseal Blue, was announced by Vivasure Medical. In particular, PerQseal Blue is made to be utilised in percutaneous cardiovascular procedures like transcatheter mitral valve repair or replacement (TMVR) and transcatheter tricuspid valve repair or replacement for suture-less, fully absorbable large-bore venous artery closure (TTVR).
• In March 2021, the main CE Mark study for CyndRx LLC's AbsorbaSealTM vascular closure device, which was designed to assess the safety and effectiveness of this polymer-based device, was completed with strong clinical results.
• In January 2021, Haemonetics Corporation and Cardiva Medical Inc., a privately held producer of vascular closure systems, signed a legally binding agreement to combine their businesses.

Global Active Approximators Vascular Closure Device (VCDs) Market Scope

The active approximators vascular closure device (VCDs) market is segmented on the basis of type, access, procedure, distribution channel, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Passive Approximators
• Collagen Plugs
• Sealant or Gel-based Devices
• Compression Assist Devices
• Active Approximators
• Suture-based Devices
• Clip-based Devices
• External Hemostatic Devices

Access

• Femoral Access
• Radial Access

Procedure

• Interventional Cardiology
• Interventional Radiology/Vascular Surgery

Distribution Channel

• Direct Tenders
•  Retail

 Application

• Diagnostic Intervention
• Therapeutic Intervention

 End User

• Hospitals
• Clinics
• Specialty Centres
• Ambulatory Surgery Centres
• Others

Active Approximators Vascular Closure Device (VCDs) Market Regional Analysis/Insights

The active approximators vascular closure device (VCDs) market is analysed and market size insights and trends are provided by country, type, access, procedure, distribution channel, application, and end user as referenced above.

The countries covered in the active approximators vascular closure device (VCDs) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominated the global active approximators vascular closure devices market, due to the increasing prevalence of cardiovascular diseases.

Asia-Pacific is expected to witness the fastest growth in the next 7 years due to the emerging economies of China and India.

La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que l'analyse de la chaîne de valeur en aval et en amont, les tendances techniques et l'analyse des cinq forces de Porter, les études de cas sont quelques-uns des indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques mondiales et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des tarifs nationaux et les routes commerciales sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Croissance des infrastructures de santé Base installée et pénétration des nouvelles technologies

Le marché mondial des dispositifs de fermeture vasculaire à approximateurs actifs (VCD) vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché mondial des dispositifs de fermeture vasculaire à approximateurs actifs (VCD), l'impact de la technologie utilisant les courbes de ligne de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché mondial des dispositifs de fermeture vasculaire à approximateurs actifs (VCD). Les données sont disponibles pour la période historique 2010-2020.

Analyse du paysage concurrentiel et des parts de marché des dispositifs de fermeture vasculaire (VCD) Active Approximators

Le paysage concurrentiel du marché des dispositifs de fermeture vasculaire à approximateurs actifs (VCD) fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination de l'application. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liée au marché des dispositifs de fermeture vasculaire à approximateurs actifs (VCD).

Certains des principaux acteurs opérant sur le marché des dispositifs de fermeture vasculaire à approximateurs actifs (VCD) sont :

• Terumo Corporation (Japon)
• Abbott (États-Unis)
• Cardinal Health (États-Unis)
• Cardiva Medical, Inc. (États-Unis)
• Medtronic (Irlande)
• Morris Innovative (États-Unis)
• Teleflex Incorporated (États-Unis)
• Systèmes médicaux Merit (États-Unis)
• Vasorum Ltd. (Irlande)
• TZ Medical, (États-Unis)
• Vivasure Medical Ltd. (Irlande)
• Tricol Biomedical (États-Unis)
• Scion Biomedical (États-Unis)
• Dynamique vasculaire avancée (US)
• Marine Polymer Technologies, Inc. (États-Unis)
• Technologies Transluminales (États-Unis)

SKU-68879